APOE and atherosclerosis: Experimental inhibition of TGFß1 in blood vessels of atherosclerosis-prone ApoE knock-out mice by specific antibodies [11] or recombinant soluble type II receptor [12] resulted in accelerated atherosclerosis or a more pro-inflammatory plaque phenotype and thus principally confirmed the putative anti-atherogenic TGFß1 properties.